Hussein Tawbi, MD, PhD, presents the case of a 78-year-old man with metastatic melanoma and shares his initial impressions.
2023
Nurse Practitioner Lisa Kottschade Discusses Immune-Related Adverse Events, Biomarkers
Lisa A. Kottschade, RN, CNP, FAPO, discussed immune-related adverse events, which she presented on at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event hosted by Minnesota Oncology in Minneapolis, Minnesota, on September 12. Kottschade, who is primarily interested in malignant melanoma treatment, also discussed the use of biomarkers.
Developing a Dielectrophoretic Method to Isolate Circulating Melanoma Cells
The AES Mid-Career Award recognizes exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career. This year’s recipient, Robbyn K. Anand, Suresh Faculty Fellow and Carlyle G.
‘Time Toxicity’ and its Effect on Patients With Stage 4 Melanoma
Patients with stage 4 melanoma experience more time toxicity, as they are expected to attend more in-person doctor visits for optimal survival, according to an expert.